TITAN: Thresholds In Food Allergy evaluaTion And predictioN

Sponsor
Hamilton Health Sciences Corporation (Other)
Overall Status
Recruiting
CT.gov ID
NCT06038019
Collaborator
AAAAI Foundation (Other), Canadian Institutes of Health Research (CIHR) (Other)
2,000
1
326
6.1

Study Details

Study Description

Brief Summary

Thresholds In food allergy evaluaTion And predictioN, a prospective, observational registry. The aim is to quantify food allergy thresholds in Canada and their clinical predictors.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Oral food challenge

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
2000 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Thresholds In Food Allergy evaluaTion And predictioN, a Prospective, Multicentre Registry Study
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2050
Anticipated Study Completion Date :
Jan 1, 2051

Arms and Interventions

Arm Intervention/Treatment
Group 1

Patients with suspected or confirmed food allergy

Diagnostic Test: Oral food challenge
Patients will undergo oral food challenge with increasing amounts of food allergen

Outcome Measures

Primary Outcome Measures

  1. Eliciting dose thresholds to food challenge [1 year]

    Threshold are measured by controlled food challenge to incremental doses of allergen (g) and are adjudicated according to CoFAR v3.0 criteria

Secondary Outcome Measures

  1. Food Allergy Quality of Life Questionnaire Child Form [1 year]

    The number of items found in the child form questionnaire includes 30 items. Food allergy quality of life questionnaire is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.

  2. Food Allergy Quality of Life Questionnaire Teen Form [1 year]

    The number of items found in the Teen Form questionnaire includes 26 items. Food allergy quality of life questionnaire is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.

  3. Food Allergy Quality of Life Questionnaire Adult Form [1 year]

    The number of items found in the Adult Form questionnaire includes 35 items. Food allergy quality of life questionnaire is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.

  4. Food Allergy Quality of Life Questionnaire Parent Form [1 year]

    The number of items found in the Parent Form questionnaire includes 38 items. Food allergy quality of life questionnaire consists of 3 to 4 domains, each question is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.

  5. Skin Prick Testing [1 year]

    Measured by mean wheal size (mm)

  6. Specific IgE [1 year]

    Measured by ImmunoCap (kU/L)

  7. Basophil Activation Test [1 year]

    Measured by flow cytometry (cell frequency basophils and median fluorescence intensity)

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Suspicion or history of food allergy based on medical history, positive skin prick test, and/or serum food-specific IgE. A suggestive history is defined as typical clinical signs and/or symptoms (urticaria, angioedema, abdominal pain, vomiting, dyspnea, wheeze) within 60 minutes of the ingestion of a food.

  2. Ability to discontinue all antihistamines for 1 week before oral food challenge.

Exclusion Criteria:
  1. Previous desensitization treatment to a food allergen

  2. Allergies to any component of the oral challenge vehicle

  3. Unstable conditions including uncontrolled asthma or chronic urticaria

  4. Any clinically significant disease/chronic medical condition which may interfere with study evaluations.

Contacts and Locations

Locations

Site City State Country Postal Code
1 McMaster University Medical Centre Hamilton Ontario Canada

Sponsors and Collaborators

  • Hamilton Health Sciences Corporation
  • AAAAI Foundation
  • Canadian Institutes of Health Research (CIHR)

Investigators

  • Principal Investigator: Derek Chu, MD PhD FRCPC, Hamilton Health Sciences & McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hamilton Health Sciences Corporation
ClinicalTrials.gov Identifier:
NCT06038019
Other Study ID Numbers:
  • NIF-20500
First Posted:
Sep 14, 2023
Last Update Posted:
Sep 14, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hamilton Health Sciences Corporation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2023